Valuation : ApicHope Pharmaceutical Group Co., Ltd.

Market Cap 16.65B 2.47B 2.13B 2B 1.83B 3.44B 237B 3.45B 23.72B 9.25B 119B 9.29B 9.09B 396B P/E 2026 *
32x
P/E 2027 * -161x
Enterprise Value 16.65B 2.47B 2.13B 2B 1.83B 3.44B 237B 3.45B 23.72B 9.25B 119B 9.29B 9.09B 396B EV / Sales 2026 *
15.4x
EV / Sales 2027 * 13.2x
Free-Float
31.84%
Yield 2026 *
-
Yield 2027 * -
1 day-1.20%
1 week+1.01%
Current month+5.16%
1 month+7.72%
3 months-8.64%
6 months+11.98%
Current year+10.64%
1 week 34.13
Extreme 34.13
37.79
1 month 33.7
Extreme 33.7
40.2
Current year 29.31
Extreme 29.31
45.88
1 year 29.31
Extreme 29.31
76.88
3 years 12.74
Extreme 12.74
81.48
5 years 12.74
Extreme 12.74
81.48
10 years 7.58
Extreme 7.577775
81.48
Manager TitleAgeSince
Chief Executive Officer 52 10/11/2015
Director of Finance/CFO 60 10/11/2015
Investor Relations Contact 38 30/12/2020
Director TitleAgeSince
Chairman 52 10/11/2015
Director/Board Member 58 10/11/2015
Chairman 50 10/11/2015
Date Insider Type Main position Quantity % Market Cap.
05/01/26 Buy

Director

4,200 0.0010%
24/11/25 Buy

Director

7,000 0.0017%
01/09/23 Buy 20,000 0.0089%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%+1.01%-43.87%+97.87% 2.47B
+0.35%+0.93%+21.08%+71.89% 48.2B
-0.08%-0.21%+55.27%+121.68% 39.97B
+0.15%+6.34%+21.70%+87.77% 12.43B
+0.25%-0.61%-9.92%+15.84% 12.03B
+0.19%0.00%+30.00%+147.62% 9.35B
+0.07%+3.80%+27.45%+46.12% 7.75B
+2.24%+8.50%+29.85%+227.84% 7.43B
+0.04%+0.37%+48.15%-11.95% 7.22B
-0.53%-1.53%-34.29%+19.67% 5.3B
Average +0.15%+2.81%+14.54%+82.43% 15.21B
Weighted average by Cap. +0.21%+1.51%+27.26%+87.41%

Financials

2026 *2027 *
Net sales 1.08B 161M 138M 130M 118M 223M 15.34B 224M 1.54B 600M 7.74B 603M 590M 25.68B 1.26B 187M 161M 151M 138M 260M 17.87B 261M 1.79B 699M 9.02B 702M 687M 29.91B
Net income 526M 78.18M 67.37M 63.16M 57.66M 109M 7.47B 109M 749M 292M 3.77B 294M 287M 12.51B -102M -15.16M -13.06M -12.25M -11.18M -21.06M -1.45B -21.13M -145M -56.7M -731M -56.92M -55.68M -2.43B
Net Debt - -
Logo ApicHope Pharmaceutical Group Co., Ltd.
ApicHope Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research and development, production and sales of pharmaceuticals. The Company mainly focuses on the fields of pediatrics drug and chronic disease drug, and its product categories cover chemical medicine (including raw materials and preparations), special Chinese patent medicine, biological vaccines and other fields. The Company’s paediatric drugs are used to treat common diseases, such as children's influenza, colds, infectious diseases, functional dyspepsia and others. The Company’s chronic disease drugs are used for treatment of cardiovascular and cerebrovascular diseases, kidney diseases, digestive system diseases, liver diseases and other diseases. The Company’s main products include Fuganlin oral liquid, clindamycin hydrochloride palmitate dispersible tablets and other products. The Company mainly conducts its business in the domestic market.
Employees
1,294
Date Price Change Volume
28/08/26 CN¥37.12 -1.20% 8,498,621
27/08/26 CN¥37.57 +4.45% 13,429,274
26/08/26 CN¥35.97 +2.74% 7,589,978
25/08/26 CN¥35.01 +1.16% 5,807,449
24/08/26 CN¥34.61 -5.82% 10,031,035

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300723 Stock